VivoSeq
Neurology

Mild Cognitive Impairment

3

Pipeline Programs↗

13

Active Trials↗

4

Companies Involved↗

Mild Cognitive Impairment is an early-stage landscape with 3 programs across 4 companies. The most active players are Eli Lilly, Badalona Serveis Assistencials, Julie Pendergast. 1 therapy is approved.

Intelligence

Pipeline Metrics

Competitive Density

35/100

Pipeline Velocity

25/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Eli Lilly logo

Eli Lilly

1 program

ApprovedB

Badalona Serveis Assistencials

0 programs

PreclinicalJ

Julie Pendergast

0 programs

PreclinicalP

Posit Science Corporation

0 programs

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

22

clinical trials

Completed9 · 41%
Recruiting6 · 27%
Active, not recruiting3 · 14%
Not yet recruiting3 · 14%
Enrolling by invitation1 · 5%

Clinical Trials

Trial Activity

22 trials

Phase II Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
Recruiting·JJohns Hopkins University·Phase 2·NCT04601038·52 enrolled
Targeting Cerebrovascular Reactivity for Precision Medicine: Pilot Trial of Atorvastatin
Recruiting·JJohns Hopkins University·Phase 2·NCT04765137·20 enrolled
Technology Tools for Cognitive Support for Health Management Activities for Aging Adults With and Without Mild Cognitive Impairment (Research Project 3)
Recruiting·WWeill Medical College of Cornell University·Preclinical·NCT07485725·120 enrolled
Neuromechanisms of Falls in Older Adults With MCI: Targeting Assessment and Training of Reactive Balance Control
Recruiting·UUniversity of Illinois at Chicago·Preclinical·NCT04938349·142 enrolled
Voice2Manage: Interactive Voice-Assisted Self-Management Intervention for Low-Income Older Adults
Recruiting·EEmory University·Preclinical·NCT06982261·20 enrolled
Feasibility of Implementing Time-restricted Eating in Women With Mild Cognitive Impairment
Recruiting·—·Preclinical·NCT05858008·15 enrolled
Enhancing Gamma Band Response in Mild Cognitive Impairment to Improve Working Memory
Active, not recruiting·UUniversity of California, San Diego·Preclinical·NCT04566900·112 enrolled
The Brain Health Champion Study: Promoting Non-pharmacological Interventions in Cognitive Disorders and Those at Risk
Active, not recruiting·BBrigham and Women's Hospital·Preclinical·NCT03772977·95 enrolled
Randomized Double Blind Study on the Efficacy of Cognitive Training in Patients With Mild Cognitive Impairment Using fMRI.
Active, not recruiting·SSão Paulo State University·Preclinical·NCT03263247·60 enrolled
LifeBio Memory: Development of a Reminiscence Therapy Online Platform With Machine Learning to Increase Engagement
Not yet recruiting·George Mason University·Preclinical·NCT07685067·168 enrolled
Improving Neurological Health With Acetylcholine Via Neuroplasticity-based Computerized Exercise in Mild Cognitive Impairment (INHANCE-MCI)
Not yet recruiting·PPosit Science Corporation·Preclinical·NCT07243600·84 enrolled
Effect of Gingko Biloba on the Blood Biomarkers in Mild Cognitive Impairment Patients With Alzheimer's Disease
Not yet recruiting·HHanyang University·Approved·NCT07579689·120 enrolled
Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4)
Enrolling by invitation·UUniversity of Southern California·N/A·NCT05617014·1,500 enrolled
Light, Metabolic Syndrome and Alzheimer's Disease: A Non-Pharmocological Approach
Completed·IIcahn School of Medicine at Mount Sinai·Preclinical·NCT03933696·25 enrolled
Behavioral Change Following Culturally Informed Biomarker Disclosure in Alzheimer's Disease
Completed·UUniversity of Michigan·Preclinical·NCT05584241·102 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)